Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
This guide weighs PoW and PoS pros and cons, outlining scenarios where one may be preferable and what trade-offs to consider for a blockchain project.
21,439 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Medicare Part B costs soar for high-income retirees due to IRMAA. The two-year lookback means past income spikes stil...
A public clash within the GOP erupts as Marjorie Taylor Green accuses Trump of placing a donor class above America Fi...
Large holders have added 820,000,000 ADA in six months, trimming circulating supply and fueling a potential ADA recov...
Retirees eye InfraCap MLP ETF AMZA for a high yield amid volatile markets. This report highlights critical factors re...
Southwest Gas missed Q4 earnings by three cents but reaffirmed its 14% annual growth target through 2030, tying the m...
Dell Technologies delivers a blowout quarter, driven by a 73% jump in Infrastructure Solutions revenue to $19.6 billi...
Four AI models project XRP’s 2026 end price in a wide band, signaling divergent bets on Ripple’s payment ambitions an...
Over the weekend, bitcoin surged to $67,000 after a sharp dip, as unverified geopolitical headlines circulated. Marke...
Dubai's tax-free haven status is under pressure as Gulf tensions intensify following iran attacks dubai. The disrupti...
Private and public sector leaders warn that Iran is expanding its AI-enabled cyber toolkit, raising the risk to banks...
When a high-profile buyout falls short of expectations, stocks swing and traders scramble for context. This deep dive...